Feasibility study of neoadjuvant chemoradiotherapy using Intensity Modulated Radiation Therapy (IMRT) with Docetaxel, CDDP and 5-Fluorouracil (DCF) for cervical esophageal cancer.
Not Applicable
- Conditions
- cervical esophageal cancer
- Registration Number
- JPRN-UMIN000018241
- Lead Sponsor
- Gunma University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
Not provided
Exclusion Criteria
1) History of serious drug hypersensitivity 2) Pregnant, lactating or women of child-bearing potential. Men who want get partner pregnant 3) Active infections 4 4) Serious complications 5) Serious heart disease 6) Peptic ulcers 7) Sensory neuropathy 8) Diarrhea 9) A case with abdominal dropsy and the hydrothorax to need a treatment 10) Brain metastasis 11) Other active malignancies (Nondisease period less than 5 years) 12) Continuous steroid treatment 13) Any other cases who are regarded as inadequate for study enrollment by the investigator 14) Administration contraindication of 5-FU, CDDP, Docetaxel
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method